Back to Results

Bavarian Nordic A/S ADR (BVNRY)

Bavarian Nordic A/S ADR is a depositary receipt listed on OTC Markets that represents common stock in Bavarian Nordic A/S, a biotechnology company focused on vaccines. Through the underlying issuer, the business develops, manufactures, and supplies vaccines for smallpox and monkeypox under the IMVAMUNE, IMVANEX, and JYNNEOS brands, along with human rabies, tick-borne encephalitis, cholera, and typhoid vaccines sold under names including Rabipur/RabAvert, Encepur, Vaxchora, and Vivotif/Typhoral. The company is also advancing MVA-BN WEV, which is in phase 2 development for encephalitis viruses. Bavarian Nordic A/S operates across North America, Europe, Asia, the Middle East, and other international markets. The company was incorporated in 1992 and is headquartered in Hellerup, Denmark.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-BVNR.Y
$13.38
25.1% Upside
Undervalued
Not available
Not available
Great
0.0%
November 13, 2026
10.5x
1.2x
2.6x
2.476 B
2.132 B
0.8%
99.9%
21.9
80.3%
Valuation • Fair Value

Bavarian Nordic A/S ADR (OTC-BVNR.Y) Fair Value by Valuation Model

Review the available estimates for Bavarian Nordic A/S ADR (OTC-BVNR.Y), including DCF Fair Value, Ben Graham Formula Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$13.38

Estimated upside of 25.1% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$14.49

Discounted cash flow valuation reference.

Ben Graham Formula Value

$11.52

Classic Ben Graham valuation formula reference.

EPV Fair Value

$13.04

Earnings power value estimate.

Comps Fair Value

$12.33

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 6 available valuation references for Bavarian Nordic A/S ADR (OTC-BVNR.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Bavarian Nordic A/S ADR (OTC-BVNR.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

968.9 M

Current operating scale indicator.

Revenue Forecast

900.8 M

Forward revenue estimate.

EBITDA

272.5 M

Current operating profitability reference.

EBITDA Forecast

274.2 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Bavarian Nordic A/S ADR (OTC-BVNR.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Bavarian Nordic A/S ADR (OTC-BVNR.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-1.71

Higher caution zone on this screen.

Altman Z-Score

21.9

Relatively strong balance-sheet zone.

FCF / Net Income

80.3%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Bavarian Nordic A/S ADR (OTC-BVNR.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Bavarian Nordic A/S ADR (OTC-BVNR.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 13, 2026

Days to Earnings

52

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Bavarian Nordic A/S ADR (OTC-BVNR.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Buy

The daily technical read for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Bavarian Nordic A/S ADR (OTC-BVNR.Y) Stock FAQ

Data-supported answers about Bavarian Nordic A/S ADR (OTC-BVNR.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$13.38
Estimated upside 25.1%
Valuation Rating
Undervalued
Estimated upside of 25.1%
Financial Health
Great
Current financial-health read

The current fair value estimate for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is $13.38. This implies an estimated upside of 25.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 25.1% versus the current market price.

The current financial health read for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is November 13, 2026.

The latest available data indicates no current dividend yield for Bavarian Nordic A/S ADR (OTC-BVNR.Y).

The current P/E ratio listed for Bavarian Nordic A/S ADR (OTC-BVNR.Y) is 10.5x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Bavarian Nordic A/S ADR is 2.476 B.

The current enterprise value listed for Bavarian Nordic A/S ADR is 2.132 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Bavarian Nordic A/S ADR is OTC-BVNR.Y, and the stock is listed on OTC Markets.

Bavarian Nordic A/S ADR (OTC-BVNR.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Bavarian Nordic A/S ADR is 0.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Bavarian Nordic A/S ADR is 99.9%. Free float helps investors understand how much of the share base is available for public trading.

Similar Biotechnology Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABBV NYSE AbbVie Inc Fair Value Fair Market Cap 468.7 B
AMGN NASDAQ Amgen Inc Fair Value Fair Market Cap 221.8 B
GILD NASDAQ Gilead Sciences Inc Fair Value Fair Market Cap 189.3 B
VRTX NASDAQ Vertex Pharmaceuticals Inc Fair Value Fair Market Cap 130.5 B
REGN NASDAQ Regeneron Pharmaceuticals Inc Fair Value Undervalued Market Cap 80.273 B
MRNA NASDAQ Moderna Inc Fair Value Overvalued Market Cap 72.885 B
ARGX NASDAQ argenx NV ADR Fair Value Fair Market Cap 61.249 B
NTRA NASDAQ Natera Inc Fair Value Overvalued Market Cap 56.346 B
ONC NASDAQ BeOne Medicines AG DRC Fair Value Fair Market Cap 41.851 B
RVMD NASDAQ Revolution Medicines Inc Fair Value Fair Market Cap 41.337 B
ALNY NASDAQ Alnylam Pharmaceuticals Inc Fair Value Fair Market Cap 33.673 B
BIIB NASDAQ Biogen Inc Fair Value Fair Market Cap 33.298 B
ROIV NASDAQ Roivant Sciences Ltd Fair Value Overvalued Market Cap 27.607 B
INSM NASDAQ Insmed Inc Fair Value Fair Market Cap 26.385 B
INCY NASDAQ Incyte Corporation Fair Value Fair Market Cap 25.728 B
BNTX NASDAQ BioNTech SE Fair Value Fair Market Cap 25.339 B
UTHR NASDAQ United Therapeutics Corporation Fair Value Fair Market Cap 21.342 B
GMAB NASDAQ Genmab AS Fair Value Overvalued Market Cap 20.853 B
ASND NASDAQ Ascendis Pharma AS Fair Value Fair Market Cap 15.602 B
NBIX NASDAQ Neurocrine Biosciences Inc Fair Value Undervalued Market Cap 14.46 B